4//SEC Filing
CymaBay Therapeutics, Inc. 4
Accession 0001179110-17-000729
CIK 0001042074operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:36 PM ET
Size
5.8 KB
Accession
0001179110-17-000729
Insider Transaction Report
Form 4
Boudes Pol F
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2017-01-04+21,000→ 42,000 totalExercise: $1.82From: 2017-01-04Exp: 2026-07-24→ Common Stock (21,000 underlying)
Footnotes (1)
- [F1]On July 25, 2016, the Reporting Person was granted an option to purchase 42,000 shares of common stock of the Issuer. The option vests in two equal installments based on the Issuer's achieving certain milestones. The first milestone was met on December 30, 2016, resulting in vesting of the option as to 21,000 shares, which was reported on a prior Form 4. The second milestone was met on January 4, 2017, resulting in vesting of the option as to the remaining 21,000 shares.
Documents
Issuer
CymaBay Therapeutics, Inc.
CIK 0001042074
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001042074
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:36 PM ET
- Size
- 5.8 KB